BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21067388)

  • 1. Management of immune thrombocytopenia--something old, something new.
    George JN
    N Engl J Med; 2010 Nov; 363(20):1959-61. PubMed ID: 21067388
    [No Abstract]   [Full Text] [Related]  

  • 2. Plateletpheresis for postsplenectomy rebound thrombocytosis in a patient with chronic immune thrombocytopenic purpura on romiplostim.
    Raval JS; Redner RL; Kiss JE
    J Clin Apher; 2013 Aug; 28(4):321-4. PubMed ID: 23450778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Romplostim in the treatment of immune thrombocytopenic purpura at a tertiary hospital].
    Riu Viladoms G; Creus Baró N; Estefanell Tejero A; Ribas Sala J
    Farm Hosp; 2012; 36(5):434-7. PubMed ID: 22871365
    [No Abstract]   [Full Text] [Related]  

  • 4. [New treatment options for primary immune thrombocytopenia].
    Gudbrandsdottir S; Frederiksen H; Birgens HS; Nielsen CH; Nielsen OJ; Stentoft J; Hasselbalch HC
    Ugeskr Laeger; 2011 Jan; 173(4):271-4. PubMed ID: 21262171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudothrombocytopenia in a patient receiving romiplostim for immune thrombocytopenic purpura.
    Fozza C; Pardini S; Marras T; Longu F; Isoni A; Contini S; Longinotti M
    Ann Hematol; 2014 May; 93(5):899-900. PubMed ID: 24081576
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of chronic immune thrombocytopenia in children with romiplostim.
    Chaturvedi S; McCrae KR
    Lancet; 2016 Jul; 388(10039):4-6. PubMed ID: 27103125
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim.
    Beck JC; Burke MJ; Tolar J
    Pediatr Blood Cancer; 2010 Mar; 54(3):490-1. PubMed ID: 19908296
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.
    Mitsuhashi K; Ishiyama M; Imai Y; Shiseki M; Mori N; Teramura M; Seshimo A; Motoji T
    Br J Haematol; 2012 Sep; 158(6):798-800. PubMed ID: 22758388
    [No Abstract]   [Full Text] [Related]  

  • 9. Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim.
    Zimrin A; Chumsri S
    Ann Hematol; 2013 Aug; 92(8):1145-6. PubMed ID: 23328792
    [No Abstract]   [Full Text] [Related]  

  • 10. Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpura.
    Gardiner EE; Thom JY; Al-Tamimi M; Hughes A; Berndt MC; Andrews RK; Baker RI
    Br J Haematol; 2010 May; 149(4):625-8. PubMed ID: 20148887
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune thrombocytopenia during childhood: new approaches to classification and management.
    Buchanan GR
    J Pediatr; 2014 Sep; 165(3):437-9. PubMed ID: 24973290
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of Immune Thrombocytopenic Purpura (ITP) with the thrombopoietin-mimetic romiplostim.
    Meletis J; Katsandris A; Raptis SD; Mantzourani M
    Med Sci Monit; 2010 Aug; 16(8):CS100-2. PubMed ID: 20671616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic thrombocytopenic purpura: advances in management.
    Neunert C
    Clin Adv Hematol Oncol; 2011 May; 9(5):404-6. PubMed ID: 21685870
    [No Abstract]   [Full Text] [Related]  

  • 14. High response rate but short-term effect of romiplostim in paediatric refractory chronic immune thrombocytopenia.
    Seidel MG; Urban C; Sipurzynski J; Beham-Schmid C; Lackner H; Benesch M
    Br J Haematol; 2014 May; 165(3):419-21. PubMed ID: 24484542
    [No Abstract]   [Full Text] [Related]  

  • 15. Remissions after long-term use of romiplostim for immune thrombocytopenia.
    Marshall AL; Scarpone R; De Greef M; Bird R; Kuter DJ
    Haematologica; 2016 Dec; 101(12):e476-e478. PubMed ID: 27587382
    [No Abstract]   [Full Text] [Related]  

  • 16. Comment on: Use of thrombopoietin receptor agonist (romiplostim) in neonatal autoimmune thrombocytopenia due to maternal immune thrombocytopenia.
    Mahat U; Talati R; Kodish E
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27706. PubMed ID: 30854752
    [No Abstract]   [Full Text] [Related]  

  • 17. Romiplostim or standard of care in patients with immune thrombocytopenia.
    Kuter DJ; Rummel M; Boccia R; Macik BG; Pabinger I; Selleslag D; Rodeghiero F; Chong BH; Wang X; Berger DP
    N Engl J Med; 2010 Nov; 363(20):1889-99. PubMed ID: 21067381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of concomitant treatment with romiplostim and warfarin in a patient with immune thrombocytopenia and severe cardiac comorbidities.
    Baldini S; Rigacci L; Carrai V; Fjerza R; Alterini R; Bosi A
    Platelets; 2013; 24(3):242-3. PubMed ID: 22646237
    [No Abstract]   [Full Text] [Related]  

  • 19. Romiplostim for the treatment of glioblastoma-related paraneoplastic autoimmune thrombocytopenia refractory to conventional therapy.
    Rodríguez-Lobato LG; Martinez-Cibrian N; Fernández-Avilés F; Gaya A; Pineda-Losada E; Esteve J
    Ann Hematol; 2016 Mar; 95(4):665-6. PubMed ID: 26787417
    [No Abstract]   [Full Text] [Related]  

  • 20. Feasible concomitant treatment with eltrombopag and oral anticoagulation in a patient with chronic immune thrombocytopenia and severe cardiac comorbidities.
    Sanchez-Gonzalez B; Ancochea A; Garcia-Pallarols F; Jimenez C; Pedro C; Besses C
    Platelets; 2014; 25(4):309-10. PubMed ID: 23444985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.